MedTrace Logo

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

NCT00833547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2014-09-09

Study results available
· View outcomes & findings →

Summary

This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compare subjects taking a placebo to those taking 3 mg of eszopiclone with regard to: sleep architecture and sleep latency as measured by actigraphy and polysomnography and sleep-dependent motor skill learning.

Conditions

Interventions

DRUG

eszopiclone

3 mg of eszopiclone at bedtime on two consecutive nights

DRUG

placebo

Placebo capsules looking identical to eszopiclone at bedtime on two consecutive nights

Sponsors & Collaborators

Principal Investigators

  • Dara S. Manoach, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00833547 on ClinicalTrials.gov